Pi Therapeutics

Pi Therapeutics is a biopharmaceutical company aiming to develop a proprietary cancer drug that inhibits the proteasome-interacting protein Rpn13, which is a novel drug target. The company intends to develop the series for Velcade-resistant multiple myel...